The multi-herbal drug STW 5 (Iberogast®): potential mechanisms for the treatment of irritable bowel syndrome

被引:0
|
作者
Voss, U. [1 ]
Michael, S. [3 ]
Hoser, S. [1 ]
Kelber, O. [2 ]
Weiser, D. [2 ]
Nieber, K. [1 ]
机构
[1] Univ Leipzig, Inst Pharm, Leipzig, Germany
[2] Steigerwald Arzneimittelwerk GmbH, Dept Sci, Darmstadt, Germany
[3] Lowen Apotheke Waldheim, Waldheim, Germany
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
95
引用
收藏
页码:29 / 29
页数:1
相关论文
共 50 条
  • [21] Fermented Vegetables as a Potential Treatment for Irritable Bowel Syndrome
    Garnas, Eirik
    CURRENT DEVELOPMENTS IN NUTRITION, 2023, 7 (03):
  • [22] Potential of natural products in the treatment of irritable bowel syndrome
    Lu, Qiang
    Tan, Daopeng
    Luo, Jingbin
    Ye, Yonghao
    Zuo, Manhua
    Wang, Siyu
    Li, Cailan
    PHYTOMEDICINE, 2022, 106
  • [23] The potential of dextofisopam for treatment of irritable bowel syndrome and inflammatory bowel disease
    Leventer, SM
    Kucharik, RE
    Keogh, JC
    Raudibaugh, K
    Galbraith, K
    Amchin, J
    Keim, KL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S279 - S279
  • [24] STW 5 in patients with irritable bowel syndrome and other functional gastrointestinal diseases: Results of a surveillance study
    Vinson, B.
    Skeib, S.
    Kelber, O.
    Raskopf, E.
    Nieber, K.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [25] Treatment of irritable bowel syndrome with Chinese herbal medicine - A randomized controlled trial
    Bensoussan, A
    Talley, NJ
    Hing, M
    Menzies, R
    Guo, A
    Ngu, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18): : 1585 - 1589
  • [27] Onset of Action and Efficiency of STW 5 in the Clinical Setting in Patients With Functional Dyspepsia and Irritable Bowel Syndrome
    Vinson, Bettina R.
    Holtmann, Gerald
    GASTROENTEROLOGY, 2013, 144 (05) : S682 - S682
  • [28] Effectiveness and safety of herbal medicines in the treatment of irritable bowel syndrome: A systematic review
    Shi, Jun
    Tong, Yao
    Shen, Jian-Gang
    Li, Hai-Xia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (03) : 454 - 462
  • [29] Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation
    Ponziani, Francesca Romana
    Pecere, Silvia
    Lopetuso, Loris
    Scaldaferri, Franco
    Cammarota, Giovanni
    Gasbarrini, Antonio
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (07) : 983 - 991
  • [30] Drug treatment options for irritable bowel syndrome - Managing for success
    Dunphy, RC
    Verne, GN
    DRUGS & AGING, 2001, 18 (03) : 201 - 211